Pentazocine Hydrochloride and Naloxone Hydrochloride - Pentazocine Hydrochloride and Naloxone Hydrochloride
Navigation: NDC > Supplier starting with: G > GAVIS PHARMACEUTICALS, LLC| Field | Value |
|---|---|
| NDC Code: | 43386-680 |
| Proprietary Name: | Pentazocine Hydrochloride and Naloxone Hydrochloride |
| Suffix: | |
| Non-Proprietary Name: | Pentazocine Hydrochloride and Naloxone Hydrochloride |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 11-05-2011 |
| Category Name: | ANDA |
| Application Number: | ANDA075735 |
| Labeler: | GAVIS PHARMACEUTICALS, LLC |
| Substance Name: | NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE |
| Active Numerator Strength: | .5; 50 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| DEA Schedule: | CIV |